NCT04156854View on ClinicalTrials.gov

Intravascular Volume Expansion to Neuroendocrine-Renal Function Profiles in Chronic Heart Failure

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

December 19, 2022

Study Completion Date

December 19, 2022

Conditions
Heart Failure
Interventions
DIAGNOSTIC_TEST

Quantitated Blood Volume Analysis

Measurement of total blood volume, composed of red blood cell mass (RBCM) and plasma volume (PV) by administering low dose iodinated I-131 labeled albumin intravenously then taking blood samples at timed increments.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04156854 - Intravascular Volume Expansion to Neuroendocrine-Renal Function Profiles in Chronic Heart Failure | Biotech Hunter | Biotech Hunter